Dr. M. Peter Marinkovich, MD
Claim this profileStanford University
Affiliated Hospitals
Stanford University
Stanford University, Dept. Of Dermatology
Clinical Trials M. Peter Marinkovich, MD is currently running
DSG3-CAART Cell Therapy
for Pemphigus Vulgaris
This trial is testing new cell therapies for patients with pemphigus vulgaris who don't respond to standard treatments. The therapies involve modifying the patient's own immune cells to better fight the disease and potentially provide long-term relief.
Recruiting
1 award
Phase 1 & 2
4 criteria
Gene Therapy
for Cancer Recurrence
The study objective is to see if BVEC induced C7 expression in Recessive Dystrophic Epidermolysis Bullosa (RDEB) skin following Squamous cell carcinoma (SCC) excision will normalize the invasive tumor microenvironment and reduce tumor recurrence. Prevention of SCC's in the RDEB subjects will increase their life span.
Recruiting
1 award
Phase 2
2 criteria
More about M. Peter Marinkovich, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments M. Peter Marinkovich, MD has experience with
- BVEC
- DSG3-CAART
- FCX-007
- Beremagene Geperpavec (B-VEC)
- Investigational Product (IP)
- PTW-002
Breakdown of trials M. Peter Marinkovich, MD has run
Epidermolysis Bullosa
Squamous Cell Carcinoma
Nail Conditions
Subcorneal Pustular Dermatosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does M. Peter Marinkovich, MD specialize in?
M. Peter Marinkovich, MD focuses on Epidermolysis Bullosa and EB Simplex. In particular, much of their work with Epidermolysis Bullosa has involved COL7A1 positive patients, or patients who are undergoing treatment.
Is M. Peter Marinkovich, MD currently recruiting for clinical trials?
Yes, M. Peter Marinkovich, MD is currently recruiting for 3 clinical trials in Stanford California. If you're interested in participating, you should apply.
Are there any treatments that M. Peter Marinkovich, MD has studied deeply?
Yes, M. Peter Marinkovich, MD has studied treatments such as BVEC, DSG3-CAART, FCX-007.
What is the best way to schedule an appointment with M. Peter Marinkovich, MD?
Apply for one of the trials that M. Peter Marinkovich, MD is conducting.
What is the office address of M. Peter Marinkovich, MD?
The office of M. Peter Marinkovich, MD is located at: Stanford University, Stanford, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.